Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 6/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | CA12 | O43570 | 2/20 | 0.51 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA2 | P00918 | 2/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31498845 | 0.80 | GAA (0.62) | GAAKDM4EALDH1A1GLAL3MBTL1 | |
| SCHEMBL11367485 | 0.78 | LMNA (0.51) | GAAKDM4EALDH1A1L3MBTL1CA1 | |
| SCHEMBL6693713 | 0.78 | GAA (0.59) | GAAKDM4EALDH1A1GLAL3MBTL1 | |
| SCHEMBL31171944 | 0.76 | GAA (0.57) | GAAKDM4EALDH1A1GLAL3MBTL1 | |
| SCHEMBL9864530 | 0.76 | GAA (0.57) | GAAKDM4EALDH1A1GLAL3MBTL1 | |
| SCHEMBL3618684 | 0.76 | KDM4E (0.56) | GAAKDM4EALDH1A1GLAL3MBTL1 | |
| SCHEMBL8701345 | 0.76 | CFD (0.63) | GAAKDM4EALDH1A1L3MBTL1CA12 | |
| SCHEMBL11852070 | 0.75 | NLRP3 (0.60) | GAAKDM4EALDH1A1GLAL3MBTL1 | |
| SCHEMBL1649522 | 0.74 | EPHX1 (0.59) | KDM4EALDH1A1SMN1; SMN2TSHRHPGD | |
| SCHEMBL6858019 | 0.73 | GAA (0.66) | GAAKDM4EALDH1A1GLAL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260128361-A1 | FUNCTIONAL ALIPHATIC AND/OR AROMATIC AMINE COMPOUNDS OR DERIVATIVES AS ELECTROLYTE ADDITIVES TO REDUCE GAS GENERATION IN LI-ION BATTERIES | ENEVATE CORP (US) | 2026-05-07 | — | — | US | disclosed |
| US-12438181-B2 | Functional aliphatic and/or aromatic amine compounds or derivatives as electrolyte additives to reduce gas generation in Li-ion batteries | ENEVATE CORPORATION (US) | 2025-10-07 | — | — | US | disclosed |
| US-20210328256-A1 | FUNCTIONAL ALIPHATIC AND/OR AROMATIC AMINE COMPOUNDS OR DERIVATIVES AS ELECTROLYTE ADDITIVES TO REDUCE GAS GENERATION IN LI-ION BATTERIES | ENEVATE CORPORATION | 2021-10-21 | — | — | US | disclosed |
| US-20210328256-A1 | FUNCTIONAL ALIPHATIC AND/OR AROMATIC AMINE COMPOUNDS OR DERIVATIVES AS ELECTROLYTE ADDITIVES TO REDUCE GAS GENERATION IN LI-ION BATTERIES | ENEVATE CORPORATION | 2021-10-21 | — | — | US | disclosed |
| WO-2021194742-A1 | FUNCTIONAL ALIPHATIC AND/OR AROMATIC AMINE COMPOUNDS OR DERIVATIVES AS ELECTROLYTE ADDITIVES TO REDUCE GAS GENERATION IN LI-ION BATTERIES | ENEVATE CORPORATION (US) | 2021-09-30 | — | — | WO | disclosed |
| WO-2021194742-A1 | FUNCTIONAL ALIPHATIC AND/OR AROMATIC AMINE COMPOUNDS OR DERIVATIVES AS ELECTROLYTE ADDITIVES TO REDUCE GAS GENERATION IN LI-ION BATTERIES | ENEVATE CORPORATION (US) | 2021-09-30 | — | — | WO | disclosed |
| US-11018371-B1 | Functional aliphatic and/or aromatic amine compounds or derivatives as electrolyte additives to reduce gas generation in li-ion batteries | ENEVATE CORPORATION (US) | 2021-05-25 | — | — | US | disclosed |
| EP-0594877-A1 | Imidazo(1,2-c)quinazoline derivates as antihyper tensives and anti dysurics | NATIONAL SCIENCE COUNCIL (TW) | 1994-05-04 | — | — | EP | disclosed |
| US-5158953-A | 2-substituted methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-ones (thiones), the preparation and use thereof | NATIONAL SCIENCE COUNCIL (TW) | 1992-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260128361-A1 | FUNCTIONAL ALIPHATIC AND/OR AROMATIC AMINE COMPOUNDS OR DERIVATIVES AS ELECTROLYTE ADDITIVES TO REDUCE GAS GENERATION IN LI-ION BATTERIES | LAGE3, ROS1, CACNA2D3 | GAA 2612/4885KDM4E 210/4885ALDH1A1 863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.